Sign In
Buy APLT
$0.0959
+0 (+0%)
At Close: Apr 28, 2026
The Schall Law Firm Invites Shareholders With Losses To Join A Securities Fraud Case Against Applied Therapeutics, Inc.
11:00am, Monday, 10'th Feb 2025
LOS ANGELES, CA / ACCESS Newswire / February 10, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Applied Therapeutics, In
NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal s
NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal s
NEW YORK, NY / ACCESS Newswire / February 10, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Applied
NEW YORK , Feb. 10, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT). Shareholders who purchased shares of APLT during
Investors in Applied Therapeutics, Inc. Should Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - APLT
05:30pm, Sunday, 09'th Feb 2025
NEW YORK, NY / ACCESS Newswire / February 9, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal se
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in Applied Therapeutics Lawsuit - APLT
11:13am, Sunday, 09'th Feb 2025
NEW YORK, NY / ACCESS Newswire / February 9, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal se
LOS ANGELES, CA / ACCESS Newswire / February 9, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Applied Therapeutics, Inc
Levi & Korsinsky Notifies Shareholders of Applied Therapeutics, Inc.(APLT) of a Class Action Lawsuit and an Upcoming Deadline
10:13am, Sunday, 09'th Feb 2025
NEW YORK, NY / ACCESS Newswire / February 9, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal se
NEW YORK, NY / ACCESS Newswire / February 9, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NAS
Contact Levi & Korsinsky by February 18, 2025 Deadline to Join Class Action Against Applied Therapeutics, Inc.(APLT)
08:23am, Sunday, 09'th Feb 2025
NEW YORK, NY / ACCESS Newswire / February 9, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal se
Levi & Korsinsky Notifies Shareholders of Applied Therapeutics, Inc.(APLT) of a Class Action Lawsuit and an Upcoming Deadline
07:13am, Sunday, 09'th Feb 2025
NEW YORK, NY / ACCESS Newswire / February 9, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal se
NEW YORK, NY / ACCESS Newswire / February 9, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Applied
NEW YORK, NY / ACCESS Newswire / February 8, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal se
NEW YORK, Feb. 08, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Applied Therapeutics, Inc. (NASDAQ: APLT) between January 3, 202
